kfda-ind-hanim

Korea FDA accepts IND application from Hanmi

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Korean Food and Drug Administration (KFDA) has accepted Hanmi Pharmaceutical's investigational new drug application for KX-01, dual src/pretubulin inhibitor... Read more

agreement-safc-crystalgenomics

Sigma-Aldrich unit enters Korea with CrystalGenomics

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Sigma-Aldrich's custom manufacturing and services business unit, SAFC, has signed an agreement with Seoul-based CrystalGenomics to support the development... Read more

us-based-cro-wcct-global-and-korea-drug-development-fund-kddf-join-hands

Korea drug dev fund joins hands with US CRO

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: WCCT Global announced a mutual cooperation and business agreement with Korea Drug Development Fund (KDDF) located in Seoul, South Korea. This will be... Read more

bad-news-for-cancer-patients-pfizer-inlyta-axitinib-fails-to-meet-primary-endpoint-in-advanced-renal-cell-carcinoma-phase-iii-trials

Pfizer trial of cancer drug INLYTA is a failure

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demonstrating statistically significantly longer... Read more

koreans-generate-stem-cells-that-be-transformed-into-any-organs

Korean stem cells that can be transformed into organs

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Korean scientists have developed a breakthrough technology that can more efficiently and safely reprogram adult cells to an embryo-like state, which can... Read more

asia-is-yet-to-see-any-blockbusters-in-life-sciences

Will the next blockbuster emerge from Asia?

  • Australia
  • |
  • Opinion
  • |
  • By Nandita Singh
  • |
  • 0 Comment

Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More importantly, will these new examples emerge from companies... Read more

shinogi-supply-agreement

Shinogi starts supply of Pirespa to Ildong

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Osaka-based Shionogi has began to supply Pirespa 200mg tablet (pirfenidone) to Ildong Pharmaceutical, which is headquartered in Seoul, for the treatment... Read more

immunoreagent-distributor

ImmunoReagents appoints new distributors in Korea, India...

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has appointed Sungwoo... Read more

icon-partners-with-korea-national-enterprise-for-clinical-trials-konect-to-advance-the-clinical-trials-industry-in-south-korea

ICON partners with Korean national clinical trials enterprise...

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Korea National Enterprise... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X